The difference between neratinib and neratinib

Neratinib (Neratinib) and neratinib are actually the same drug, but their Chinese translations are different. The two drugs are completely identical in terms of drug ingredients, mechanism of action, indications, and manufacturers. The English common name is Neratinib. It is an oral small molecule irreversible pan-HER receptor tyrosine kinase inhibitor. It is mainly used to treat patients with HER2-positive breast cancer.

This difference in names mainly comes from the difference in Chinese translation methods. In mainland China, some information and media translate "Neratinib" as "neratinib", while in Hong Kong, Macao and Taiwan and some imported drug instructions, it is called "neratinib". Although the names are slightly different, in clinical use they refer to the exact same drug, so patients do not have to be confused by translation differences when reading drug information.

Neratinib (neratinib) works by inhibiting HER1, HER2 and H The kinase activity of ER4 and other receptors can effectively block the growth and spread of cancer cells, especially for HER2 positive breast cancer postoperative adjuvant therapy and some patients with brain metastasis. In multiple international clinical studies, the drug has shown advantages in extending disease-free survival and reducing the risk of recurrence.

To sum up, whether it is called "neratinib" or "neratinib", it is essentially Neratinib a targeted drug. Patients do not need to worry about differences due to different names when taking medicines. The key is to pay attention to the regular sources of medicines, indications for use and doctor's recommendations to ensure safe and effective treatment.

Reference materials:https://www.drugs.com/